Metraipolis › archive › dc_ad954afea570
Targeting SUMOylation in glioblastoma: A novel avenue for therapy and biomarker discovery — Europe PMC PMID:41659205
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41659205
- DOI
- 10.1016/j.gendis.2025.101841
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:39:19.389Z
- SHA-256 of the archived text
23f4d7001d423765b772a2e6713a9e911cc5c39303c499c733e9429c3e4af5f0- Stable URL of this page
https://metraipolis.com/documento/dc_ad954afea570
How to cite
Targeting SUMOylation in glioblastoma: A novel avenue for therapy and biomarker discovery — Europe PMC PMID:41659205 — Europe PMC (en), https://europepmc.org/article/MED/41659205 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad954afea570 (Metraipolis archive dc_ad954afea570, sha256 23f4d7001d423765b772a2e6713a9e911cc5c39303c499c733e9429c3e4af5f0)
BibTeX
@misc{dcad954afea570,
title = {Targeting SUMOylation in glioblastoma: A novel avenue for therapy and biomarker discovery — Europe PMC PMID:41659205},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41659205},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad954afea570; sha256 23f4d7001d423765b772a2e6713a9e911cc5c39303c499c733e9429c3e4af5f0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41659205. Agents can read the archived copy with the MCP tool read_document.